Trial intelligence / Profile preview

Single-dose placebo-controlled study of two Strepsils flavour lozenges for sore throat relief

2008-005596-10Phase 3Completed

Sponsor
Reckitt
Start
Nov 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of amylmetacresol + 2,4-dichlorobenzyl alcohol, amylmetacresol and 2,4-dichlorobenzyl alcohol in upper respiratory infection (URI) (3 arms), sponsored by Reckitt. Primary endpoint: Area under the change from baseline curve in throat soreness. Started Nov 2008; status: completed.

02

Drugs

amylmetacresol + 2,4-dichlorobenzyl alcoholamylmetacresol2,4-dichlorobenzyl alcohol
03

Conditions

upper respiratory infection (URI)

Beyond the preview

Go deeper on 2008-005596-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005596-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call